Procurement Summary
Country: Brazil
Summary: Future and Eventual Acquisition of Medicines for Human Use (Brintellix, Buspirone Hydrochloride, Paroxetine Hydrochloride and Others), which will be Used to Comply with Court Decisions, In...
Deadline: 26 Nov 2025
Posting Date: 07 Nov 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 129723762
Document Ref. No.: 90537/2025
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Future and eventual acquisition of medicines for human use (brintellix, buspirone hydrochloride, paroxetine hydrochloride and others), which will be used to comply with court decisions, in compliance with the Uberlandia Municipal Health Department.
UASG Code: 926922
Notice from: 07/11/2025 from 08:00 to 17:00
Proposal Delivery: from 11/07/2025 at 08:00
VORTIOXETINE, COMPOSITION SALT BROMYDRATE, CONCENTRATION 10 MG
Quantity: 1440
CLOPIDOGREL, DOSAGE 75 MG
BUSPIRONE HYCLORHYDRATE, CONCENTRATION 10 MG
Quantity: 1440
PAROXETINE HYCLORHYDRATE, DOSAGE 20 MG
Quantity: 4320
METHYLFENIDATE HYCLORIDATE, DOSAGE 18 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE
Quantity: 1440
METHYLFENIDATE HYCLORIDATE, DOSAGE 36 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE
METHYLFENIDATE HYCLORIDATE, DOSAGE 54 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE
Quantity: 2160
FLURAZEPAM, DOSAGE 30 MG
Quantity: 720
SODIUM DIVALPROATE, CONCENTRATION 125 MG
Quantity: 4320
TESTOSTERONE, COMPOSITION CYPIONATE SALT, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 34
DESVENLAFAXINE, COMPOSITION SUCCINATE SALT, CONCENTRATION 100 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE
Quantity: 2160
FLUDROCORTISONE ACETATE, CONCENTRATION 0.1 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION, SPECIALLY MANIPULATED FORMULATION
Quantity: 1440
BIMATOPROST, COMPOSITION ASSOCIATED WITH TIMOLOL MALEATE, CONCENTRATION 0.3 MG + 5 MG/ML, PHARMACEUTICAL FORM OPHTHALMIC SOLUTION
Quantity: 40
EMPAGLIFLOZIN, CONCENTRATION 25 MG
Quantity: 2160
LEVETIRACETAM, CONCENTRATION 250 MG
Quantity: 9500
INSULIN, ASPART TYPE, COMPOSITION WITH NICOTINAMIDE (VIT B3), CONCENTRATION 100 IU/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONS WITH APPLICATION SYSTEM
Quantity: 700
SUPPLEME...
Documents
Tender Notice